Proteasome, a promising therapeutic target for multiple diseases beyond cancer

16Citations
Citations of this article
44Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Proteasome is vital for intracellular protein homeostasis as it eliminates mis-folded and damaged protein. Inhibition of proteasome has been validated as a powerful strategy for anti-cancer therapy, and several drugs have been approved for treatment of multiple myeloma. Recent studies indicate that proteasome has potent therapeutic effects on a variety of diseases besides cancer, including parasite infectious diseases, bacterial/fungal infections diseases, neurodegenerative diseases and autoimmune diseases. In this review, recent developments of proteasome inhibitors for various diseases and related structure activity relationships are going to be summarized.

Cite

CITATION STYLE

APA

Cao, Y., Zhu, H., He, R., Kong, L., Shao, J., Zhuang, R., … Zhang, J. (2020). Proteasome, a promising therapeutic target for multiple diseases beyond cancer. Drug Design, Development and Therapy. Dove Medical Press Ltd. https://doi.org/10.2147/DDDT.S265793

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free